Consistent with elevated TGFβ expression, the levels of p-Smad2 (Fig. 5c, d) and p-Smad3 (Fig. 5e, f) in the post-PELD IVDs were also significantly higher than those in the normal healthy IVDs. The gene discussed is SMAD2; the disease is severe neurodegenerative syndrome with lipodystrophy.